BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31097988)

  • 21. Replacement of the 4'-hydroxy group of amodiaquine and amopyroquine by aromatic and aliphatic substituents: synthesis and antimalarial activity.
    Păunescu E; Susplugas S; Boll E; Varga R; Mouray E; Grosu I; Grellier P; Melnyk P
    ChemMedChem; 2009 Apr; 4(4):549-61. PubMed ID: 19212949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola.
    Guthmann JP; Ampuero J; Fortes F; van Overmeir C; Gaboulaud V; Tobback S; Dunand J; Saraiva N; Gillet P; Franco J; Denoncin A; van Herp M; Balkan S; Dujardin JC; D'Alessandro U; Legros D
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):485-92. PubMed ID: 15876443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4-aminoquinoline-pyrimidine molecular hybrids.
    Maurya SS; Khan SI; Bahuguna A; Kumar D; Rawat DS
    Eur J Med Chem; 2017 Mar; 129():175-185. PubMed ID: 28222317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children.
    Sowunmi A
    Ann Trop Med Parasitol; 2002 Apr; 96(3):227-38. PubMed ID: 12061970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
    Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
    Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
    Ogungbamigbe TO; Ojurongbe O; Ogunro PS; Okanlawon BM; Kolawole SO
    Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):79-84. PubMed ID: 18368238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organoarsenic Compounds with In Vitro Activity against the Malaria Parasite
    Basova S; Wilke N; Koch JC; Prokop A; Berkessel A; Pradel G; Ngwa CJ
    Biomedicines; 2020 Aug; 8(8):. PubMed ID: 32748808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity.
    Manohar S; Rajesh UC; Khan SI; Tekwani BL; Rawat DS
    ACS Med Chem Lett; 2012 Jul; 3(7):555-9. PubMed ID: 24900509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
    Obua C; Gustafsson LL; Aguttu C; Anokbonggo WW; Ogwal-Okeng JW; Chiria J; Hellgren U
    Acta Trop; 2006 Nov; 100(1-2):142-50. PubMed ID: 17113554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
    Checchi F; Roddy P; Kamara S; Williams A; Morineau G; Wurie AR; Hora B; Lamotte Nd; Baerwaldt T; Heinzelmann A; Danks A; Pinoges L; Oloo A; Durand R; Ranford-Cartwright L; Smet M;
    Trop Med Int Health; 2005 Feb; 10(2):146-53. PubMed ID: 15679557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
    Fowler VG; Lemnge M; Irare SG; Malecela E; Mhina J; Mtui S; Mashaka M; Mtoi R
    J Trop Med Hyg; 1993 Dec; 96(6):337-45. PubMed ID: 8254710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity.
    Chopra R; Chibale K; Singh K
    Eur J Med Chem; 2018 Mar; 148():39-53. PubMed ID: 29454189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antimalarial activity of new isotebuquine analogues.
    Miroshnikova OV; Hudson TH; Gerena L; Kyle DE; Lin AJ
    J Med Chem; 2007 Feb; 50(4):889-96. PubMed ID: 17266295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
    Hamour S; Melaku Y; Keus K; Wambugu J; Atkin S; Montgomery J; Ford N; Hook C; Checchi F
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):548-54. PubMed ID: 15869770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimalarial activity of isoquine against Kenyan Plasmodium falciparum clinical isolates and association with polymorphisms in pfcrt and pfmdr1 genes.
    Okombo J; Kiara SM; Abdirahman A; Mwai L; Ohuma E; Borrmann S; Nzila A; Ward S
    J Antimicrob Chemother; 2013 Apr; 68(4):786-8. PubMed ID: 23169890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana.
    Oduro AR; Anyorigiya T; Hodgson A; Ansah P; Anto F; Ansah NA; Atuguba F; Mumuni G; Amankwa J
    Trop Med Int Health; 2005 Mar; 10(3):279-84. PubMed ID: 15730512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action.
    Ginsburg H; Famin O; Zhang J; Krugliak M
    Biochem Pharmacol; 1998 Nov; 56(10):1305-13. PubMed ID: 9825729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents.
    Bekhit AA; Saudi MN; Hassan AMM; Fahmy SM; Ibrahim TM; Ghareeb D; El-Seidy AM; Nasralla SN; Bekhit AEA
    Eur J Med Chem; 2019 Feb; 163():353-366. PubMed ID: 30530172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.